Media stories about Aetna (NYSE:AET) have trended somewhat positive on Monday, Accern Sentiment reports. Accern ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Aetna earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave news articles about the company an impact score of 44.5849825069024 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
These are some of the news articles that may have effected Accern Sentiment’s scoring:
- Aetna Inc (AET) Position Trimmed by Suntrust Banks Inc. (americanbankingnews.com)
- 7,000 Shares in Aetna Inc (AET) Acquired by Dumac Inc. (americanbankingnews.com)
- K2 Principal Fund L.P. Acquires Shares of 15,000 Aetna Inc (AET) (americanbankingnews.com)
- Aetna Inc (AET) Stake Raised by RDL Financial Inc. (americanbankingnews.com)
- FDx Advisors Inc. Sells 1,827 Shares of Aetna Inc (AET) (americanbankingnews.com)
AET has been the topic of a number of recent research reports. Piper Jaffray Companies upgraded shares of Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 price target on the stock in a research report on Wednesday, January 3rd. ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Morgan Stanley downgraded shares of Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 price target on the stock. in a research report on Wednesday, December 20th. Argus downgraded shares of Aetna from a “buy” rating to a “hold” rating and set a $185.00 price target on the stock. in a research report on Wednesday, December 6th. Finally, Jefferies Group raised their price target on shares of Aetna from $165.00 to $185.00 and gave the stock a “hold” rating in a research report on Wednesday, November 1st. Nine equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $189.50.
Aetna (NYSE:AET) last released its quarterly earnings results on Tuesday, January 30th. The company reported $1.25 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.07. Aetna had a net margin of 3.15% and a return on equity of 21.50%. The company had revenue of $14.74 billion for the quarter, compared to the consensus estimate of $14.79 billion. During the same period in the previous year, the firm earned $0.08 EPS. Aetna’s revenue was down 6.2% on a year-over-year basis. sell-side analysts anticipate that Aetna will post 10.99 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Thursday, April 12th will be given a dividend of $0.50 per share. The ex-dividend date is Wednesday, April 11th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.14%. Aetna’s dividend payout ratio (DPR) is 33.06%.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.